Live Quote · OTCDLTNFHealthcare · Drug Manufacturers - Specialty & Generic

Delta 9 Cannabis Inc.

$0.01▼ 1.95%($-0.00)

TickerSpark Score

48/100

▌ Weak

60

Valuation

40

Profitability

90

Growth

20

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DLTNF research report →

52-Week Range4% of range

Low

$0.01

Current

$0.01

High

$0.03

Company Overviewwww.delta9.ca

About the company

Delta 9 Cannabis Inc. is a comprehensive, integrated enterprise within the cannabis sector. Leveraging its subsidiary, Delta 9 Bio-Tech Inc.

CEO: John William Arbuthnot IV
IPO: 2017
Employees: 200
HQ: Winnipeg, MB, CA

Price Chart

-52.10% · this period

Valuation

Market Cap: $3.04M
P/E: -0.05
P/S: 0.02
P/B: -0.12
EV/EBITDA: -52.73
Div Yield: 0.00%

Profitability

Gross Margin: -3.38%
Op Margin: -30.57%
Net Margin: -24.65%
ROE: 4898.73%
ROIC: -36.66%

Growth & Income

Revenue: $71.07M · 12.39%
Net Income: $-17,515,339 · 37.70%
EPS: $-0.10 · 54.55%
Op Income: $-13,493,164
FCF YoY: 159.29%

Performance & Tape

52W High: $0.03
52W Low: $0.01
50D MA: $0.01
200D MA: $0.01
Beta: 1.13
Avg Volume: 40.43K

Get TickerSpark's AI analysis on DLTNF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · DLTNF